COVID-19

FDA discloses vaccine guidelines blocked by White House

A subject receives a shot
A subject receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19 at the Kaiser Permanente Washington Health Research Institute in Seattle in March.
Ted S. Warren | AP Photo file